Please wait while the formulary information is being retrieved.
ALTUVIIIO (antihemophilic factor rFVIII Fc-VWF-XTEN,BDD-ehtl)
- hemophilia A
- bleeding in hemophilia A
- bleeding prevention in hereditary factor VIII deficiency
1,000 (+/-) unit intravenous solution
- Dosage information is not available
2,000 (+/-) unit intravenous solution
- Dosage information is not available
250 (+/-) unit intravenous solution
- Dosage information is not available
3,000 (+/-) unit intravenous solution
- Dosage information is not available
4,000 (+/-) unit intravenous solution
- Dosage information is not available
500 (+/-) unit intravenous solution
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- No disease contraindications
ALTUVIIIO (antihemophilic factor rFVIII Fc-VWF-XTEN,BDD-ehtl)
- hemophilia A
- bleeding in hemophilia A
- bleeding prevention in hereditary factor VIII deficiency
- None
- Dizziness
- Fever
- Headache disorder
- Injection site sequelae
- Nausea
More Frequent
Severe
Less Severe
- Allergic dermatitis
- Anaphylaxis
- Angioedema
- Dyspnea
- Erythema
- Fibrinogen excess
- Skin rash
- Thrombotic disorder
- Urticaria
- Chest discomfort
- Chills
- Drowsy
- Dyspepsia
- Flushing
- Insomnia
- Lethargy
- Pruritus of skin
- Upper respiratory infection
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute myocardial infarction
- Cerebrovascular accident
- Chest tightness
- Disseminated intravascular coagulation
- Hemolytic anemia
- Hypersensitivity drug reaction
- Hypertension
- Injection site infection
- Pulmonary thromboembolism
- Thromboembolic disorder
- Wheezing
Less Severe
- Acute abdominal pain
- Cough
- Diarrhea
- Dysgeusia
- Fatigue
- Hypotension
- Paresthesia
- Tachycardia
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Antihemophilic Factor,recombinant
- Severity Level:
2
- Additional Notes: Insufficient data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Antihemophilic Factor,recombinant
Insufficient human data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Bleeding episode in hemophilia A | |
| D66 | Hereditary factor VIII deficiency |
| Z14.02 | Symptomatic hemophilia A carrier |
| Bleeding prevention in hereditary factor VIII deficiency | |
| D66 | Hereditary factor VIII deficiency |
| Hemophilia A | |
| D66 | Hereditary factor VIII deficiency |
| Z14.02 | Symptomatic hemophilia A carrier |
| 0-9 | A-Z |
|---|---|
| D66 | Hereditary factor VIII deficiency |
| D66 | Hereditary factor VIII deficiency |
| D66 | Hereditary factor VIII deficiency |
| Z14.02 | Symptomatic hemophilia A carrier |
| Z14.02 | Symptomatic hemophilia A carrier |
Formulary Reference Tool